Ads
related to: prostate+cancer%2C+cell- nmCRPC Treatment Option
31% Risk of Death Decrease
Visit The Patient Site.
- Dosing & Administration
View Recommended Dosage & Learn
About Drug Interactions Here.
- Clinical Information
Read About A Double-Blind, Placebo-
Controlled, Randomized Study.
- Downloadable Resources
Resources For Physicians & Patients
Available On The Site To Download.
- nmCRPC Treatment Option
Search results
Rutgers Cancer Institute and RWJBarnabas Health Set to Unveil Extensive, New Cancer Research...
WKRN Nashville· 6 days agoClinicians and scientists from Rutgers Cancer Institute and RWJBarnabas Health will lead sessions and present their latest discoveries from their innovative cancer ...
AMGEN TO PRESENT INNOVATIVE RESEARCH FROM ITS ROBUST ONCOLOGY PORTFOLIO AT ASCO 2024
Morningstar· 2 days agoData From Newly FDA-Approved IMDELLTRA™ (tarlatamab-dlle) Further Reinforce Leadership in Bispecific T-Cell Engagers Overall Survival Data from Phase 3 LUMAKRAS® (sotorasib ...
ASCO: Large precision oncology study identifies di | Newswise
Newswise· 6 days agoA new study led by a UCLA-VA collaborative team looking at the landscape of genomic alterations in more than 5,000 veterans with metastatic prostate cancer
ASCO: J&J's radioligand spurs responses, but 4 deaths mar early results
FierceBiotech· 6 days agoJNJ-6420 is an anti-hK2 antibody-based targeted radioligand therapy that's designed to deliver a...
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a...
CNBC· 7 days agoBig pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 2 days agoCortechs.ai, a market leader in the quantitative imaging space for over a decade with their flagship product NeuroQuant, is now formally expanding beyond neuroradiology with the widespread commercialization ...
Cedars-Sinai Experts Present Cancer News at ASCO A | Newswise
Newswise· 6 days agoCedars-Sinai Cancer physician-scientists and thought leaders will discuss scientific advances, new therapies, and the future of cancer care at the American
Advances in highly targeted radiation treatment for cancer have ignited interest in a once obscure...
Nature· 1 day agoTherapies that treat while diagnosing — theranostics — can extend length of survival and improve the...
Breast Cancer in Young Women: Rates Rise, Guidelines Shift
WebMD· 20 hours agoBreast cancer does not discriminate based on age. Women across the world are increasingly becoming diagnosed with breast cancer under the age of 40. Researchers ...
KDM5B promotes SMAD4 loss-driven drug resistance through activating DLG1/YAP to induce lipid...
Nature· 6 days agoInactivated suppressor of mothers against decapentaplegic homolog (SMAD) 4 significantly affects cancer development in pancreatic ductal adenocarcinoma (PDAC). However, the ...